注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Zai Lab Ltd是一家主要从事生物制药的控股公司该公司致力于发现或许可、开发和商业化专有疗法,以解决中国市场中大量未满足医疗需求的领域,包括肿瘤学、自身免疫和传染病。该公司拥有从发现阶段到临床项目后期的一系列专利候选药物。其中包括Niraparib(ZL-2306)、ZL-2103和ZL-1101等。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Ying Du | 55 | 2014 | Founder, Chairperson & CEO |
Peter Wirth | 71 | 2017 | Independent Director |
Scott W. Morrison | 64 | 2021 | Independent Director |
Leon O. Moulder | 65 | 2020 | Independent Director |
John D. Diekman | 80 | 2017 | Lead Independent Director |
Wing Yu Leung | 53 | 2014 | Independent Director |
William David Lis | 59 | 2018 | Independent Director |
Neal Rosen | 73 | 2016 | Member of Scientific Advisory Board |
Kaixian Chen | 77 | 2018 | Independent Director |
Richard B. Gaynor | 73 | 2021 | Independent Director |
Timothy A. Yap | 48 | 2019 | Member of Scientific Advisory Board |
Lieping Chen | 66 | 2019 | Member of Scientific Advisory Board |
Alex A. Adjei | 67 | - | Member of Scientific Advisory Board |
Michel Vounatsos | 61 | 2023 | Independent Director |
Yingyu Liang | 52 | 2014 | Independent Director |
Wing-Yu Leung | 53 | 2014 | Independent Director |
Wing-Yu Leung | 53 | 2014 | Independent Director |
Wing-Yu Leung | 53 | 2014 | Independent Director |
Wing-Yu Leung | 53 | 2014 | Independent Director |
Wing-Yu Leung | 53 | 2014 | Independent Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核